JONATHAN SLONIN
CIK 1875723 · Chief Medical Officer · last filed 2026-06-05
JONATHAN SLONIN is a Chief Medical Officer who has filed 21 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider had shares withheld for taxes covering $105.5K of PCRX on Jun 5, 2026. Across all open-market trades the lifetime net is −$557.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.03M
1
21
-$557.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCRX | Chief Medical Officer | 218,912 | $22.99 | $5.03M | -$557.4K | 21 | 2026-06-05 |
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | PCRX | Tax (F) | −4,728 | -$105.5K | EDGAR |
| 2026-03-19 | PCRX | Sell (S) | −3,261 | -$74.4K | EDGAR |
| 2026-02-13 | PCRX | Grant (A) | +54,546 | $0 | EDGAR |
| 2026-02-03 | PCRX | Tax (F) | −6,168 | -$126.7K | EDGAR |
| 2026-01-06 | PCRX | Tax (F) | −381 | -$9.3K | EDGAR |
| 2025-11-19 | PCRX | Sell (S) | −3,960 | -$95.4K | EDGAR |
| 2025-08-04 | PCRX | Tax (F) | −315 | -$7.0K | EDGAR |
| 2025-06-05 | PCRX | Tax (F) | −5,084 | -$134.2K | EDGAR |
| 2025-02-04 | PCRX | Grant (A) | +93,600 | $0 | EDGAR |
| 2025-01-06 | PCRX | Mixed | −1,250 | -$23.0K | EDGAR |